Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Exact Sciences Corp (EXAS)  
$41.58 0.68 (1.61%) as of 4:30 Thu 4/17


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 185,000,000
Market Cap: 7.69(B)
Last Volume: 3,157,662 Avg Vol: 2,038,629
52 Week Range: $40.31 - $71.93
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
    NASDAQ COMPOSITE     NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    : 11.4
Insider 3/6 Months : 12
Guru Rank Number :  64
Guru Rank Value     : 12.4
Guru Occurances    : 3

 

            6 Months   1 Year   2 Year  
 
Company Profile   Exact Sciences is a cancer screening and diagnostics company. Co.'s primary screening product, the Cologuard® test, is a non-invasive stool-based DNA screening test that utilizes a multi-target approach to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. Co.'s portfolio of Oncotype tests include: Oncotype DX gene expression tests for breast, prostate and colon cancers; Oncotype DX AR-V7 Nucleus Detect® test, a liquid-based test for advanced stage prostate cancer; and Oncotype MAP™ Pan-Cancer Tissue test (oncomap test), a test delivering tumor profiling to aid therapy selection for patients with metastatic, refractory or recurrent cancer.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 19,500 19,500 19,500
Total Buy Value $0 $1,001,325 $1,001,325 $1,001,325
Total People Bought 0 1 1 1
Total Buy Transactions 0 1 1 1
Total Shares Sold 0 0 3,696 183,739
Total Sell Value $0 $0 $240,615 $12,623,736
Total People Sold 0 0 8 11
Total Sell Transactions 0 0 10 68
End Date 2025-01-19 2024-10-18 2024-04-19 2023-04-20

   
Records found: 789
  Page 1 of 32  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Bloomer Aaron EVP, Chief Financial Officer   •       –      –    2025-04-15 4 D $44.25 $479,537 D/D (10,837) 13,623     -
   Bloomer Aaron EVP, Chief Financial Officer   •       –      –    2025-04-15 4 OE $0.00 $0 D/D 24,460 19,340     -
   Conroy Kevin T President and CEO   •       •      –    2025-03-07 4 D $47.06 $2,302,599 D/D (48,929) 1,154,340     -
   Conroy Kevin T President and CEO   •       •      –    2025-03-07 4 OE $22.38 $1,493,261 D/D 66,723 1,203,269     -
   Condella Sarah EVP, Human Resources   •       –      –    2025-03-03 4 GD $0.00 $0 D/D 1,055 81,483     -
   Herriott James SVP, General Counsel & Sec   •       –      –    2025-02-28 4 D $47.82 $95,927 D/D (2,006) 15,222     -
   Herriott James SVP, General Counsel & Sec   •       –      –    2025-02-28 4 OE $0.00 $0 D/D 4,265 16,339     -
   Conroy Kevin T President and CEO   •       •      –    2025-02-28 4 D $47.82 $906,046 D/D (18,947) 1,136,546     -
   Conroy Kevin T President and CEO   •       •      –    2025-02-28 4 OE $0.00 $0 D/D 40,310 1,146,965     -
   Orville Jacob A EVP, GM, Screening   •       –      –    2025-02-28 4 D $47.82 $217,438 D/D (4,547) 25,402     -
   Orville Jacob A EVP, GM, Screening   •       –      –    2025-02-28 4 OE $0.00 $0 D/D 9,673 27,728     -
   Condella Sarah EVP, Human Resources   •       –      –    2025-02-28 4 D $47.82 $173,969 D/D (3,638) 82,538     -
   Condella Sarah EVP, Human Resources   •       –      –    2025-02-28 4 OE $0.00 $0 D/D 7,738 84,399     -
   Baranick Brian EVP, GM, Precision Oncology   •       –      –    2025-02-28 4 D $47.82 $234,940 D/D (4,913) 22,593     -
   Baranick Brian EVP, GM, Precision Oncology   •       –      –    2025-02-28 4 OE $0.00 $0 D/D 9,673 25,106     -
   Orville Jacob A EVP, GM, Screening   •       –      –    2025-02-25 4 D $51.28 $95,330 D/D (1,859) 20,277     -
   Orville Jacob A EVP, GM, Screening   •       –      –    2025-02-25 4 OE $0.00 $0 D/D 3,954 22,136     -
   Conroy Kevin T President and CEO   •       •      –    2025-02-25 4 D $51.28 $317,680 D/D (6,195) 1,115,183     -
   Conroy Kevin T President and CEO   •       •      –    2025-02-25 4 OE $0.00 $0 D/D 13,180 1,121,378     -
   Herriott James SVP, General Counsel & Sec   •       –      –    2025-02-25 4 D $51.28 $39,742 D/D (775) 12,963     -
   Herriott James SVP, General Counsel & Sec   •       –      –    2025-02-25 4 OE $0.00 $0 D/D 1,647 13,738     -
   Baranick Brian EVP, GM, Precision Oncology   •       –      –    2025-02-25 4 D $51.28 $102,970 D/D (2,008) 17,833     -
   Baranick Brian EVP, GM, Precision Oncology   •       –      –    2025-02-25 4 OE $0.00 $0 D/D 3,954 19,841     -
   Condella Sarah EVP, Human Resources   •       –      –    2025-02-25 4 D $51.28 $95,330 D/D (1,859) 78,438     -
   Condella Sarah EVP, Human Resources   •       –      –    2025-02-25 4 OE $0.00 $0 D/D 3,954 80,297     -
  789 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 1 of 32
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2025 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us